Oxidative imbalance in alzheimer’s disease (original) (raw)

• Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609–1623.
  Article PubMed CAS Google Scholar
• Joseph J., Shukitt-Hale B., Denisova N.A., et al. (2001) Copernicus revisited: amyloid beta in Alzheimer’s disease. Neurobiol. Aging 22, 131–146.
  Article PubMed CAS Google Scholar
• Hirai K., Aliev G., Nunomura A., et al. (2001) Mitochondrial abnormalities in Alzheimer’s disease. J. Neurosci. 21, 3017–3023.
  PubMed CAS Google Scholar
• Zhu X., Raina A.K., Perry G., and Smith M.A. (2004) Alzheimer’s disease: the two-hit hypothesis. Lancet Neurol. 3, 219–226.
  Article PubMed CAS Google Scholar
• Smith M.A., Rottkamp C.A., Nunomura A., et al. (2000) Oxidative stress in Alzheimer’s disease. Biochim. Biophys. Acta 1502, 139–144.
  PubMed CAS Google Scholar
• Good P.F., Werner P., Hsu A., et al. (1996) Evidence of neuronal oxidative damage in Alzheimer’s disease. Am. J. Pathol. 149, 21–28.
  PubMed CAS Google Scholar
• Smith M.A., Richey Harris P.L., Sayre L.M., et al. (1997) Widespread peroxynitrite-mediated damage in Alzheimer’s disease. J. Neurosci. 17, 2653–2657.
  PubMed CAS Google Scholar
• Smith M.A., Perry G., Richey P.L., et al. (1996) Oxidative damage in Alzheimer’s. Nature 382, 120–121.
  Article PubMed CAS Google Scholar
• Castegna A., Thongboonkerd V., Klein J.B., et al. (2003) Proteomic identification of nitrated proteins in Alzheimer’s disease brain. J. Neurochem. 85, 1394–1401.
  Article PubMed CAS Google Scholar
• Williamson K.S., Gabbita S.P., Mou S., et al. (2002) The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide 6, 221–227.
  Article PubMed CAS Google Scholar
• Sayre L.M., Smith M.A., and Perry G. (2001) Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8, 721–738.
  PubMed CAS Google Scholar
• Smith M.A., Sayre L.M., Anderson V.E., et al. (1998) Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine. J. Histochem. Cytochem. 46, 731–735.
  PubMed CAS Google Scholar
• Montine T.J., Amarnath V., Martin M.E., et al. (1996) E-4-Hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 148, 89–93.
  PubMed CAS Google Scholar
• Sayre L.M., Zelasko D.A., Harris P.L., et al. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer’s disease. J. Neurochem. 68, 2092–2097.
  Article PubMed CAS Google Scholar
• Nunomura A., Perry G., Pappolla M.A., et al. (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer’s disease. J. Neurosci. 19, 1959–1964.
  PubMed CAS Google Scholar
• Rottkamp C.A., Nunomura A., Raina A.K., et al. (2000) Oxidative stress, antioxidants, and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 14(Suppl. 1), S62-S66.
  PubMed CAS Google Scholar
• Rinaldi P., Polidori M.C., Metastasio A., et al. (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol. Aging 24, 915–919.
  Article PubMed CAS Google Scholar
• Riviere S., Birlouez-Aragon I., Nourhashemi F., and Vellas B. (1998) Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int. J. Geriatr. Psychiatry 13, 749–754.
  Article PubMed CAS Google Scholar
• Bourdel-Marchasson I., Delmas-Beauvieux M.C., Peuchant E., et al. (2001) Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 30, 235–241.
  Article PubMed CAS Google Scholar
• Lovell M.A., Xie C., and Markesbery W.R. (1998) Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer’s disease. Neurology 51, 1562–1566.
  PubMed CAS Google Scholar
• Riviere S., Birlouez-Aragon I., and Vellas B. (1998) Plasma protein glycation in Alzheimer’s disease. Glycoconj. J. 15, 1039–1042.
  Article PubMed CAS Google Scholar
• Pratico D. (2002) Alzheimer’s disease and oxygen radicals: new insights. Biochem. Pharmacol. 63, 563–567.
  Article PubMed CAS Google Scholar
• Markesbery W.R. and Carney J.M. (1999) Oxidative alterations in Alzheimer’s disease. Brain Pathol. 9, 133–146.
  Article PubMed CAS Google Scholar
• Markesbery W.R. and Lovell M.A. (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer’s disease. Neurobiol. Aging 19, 33–36.
  Article PubMed CAS Google Scholar
• Pratico D., Trojanowski J.Q., Rokach J., et al. (1998) Increased F2-isoprostanes in Alzheimer’s disease: evidence for enhanced lipid peroxidation in vivo. FASEB J. 12, 1777–1783.
  PubMed CAS Google Scholar
• Montine T.J., Beal M.F., Cudkowicz M.E., et al. (1999) Increased CSF F2-isoprostane concentration in probable AD. Neurology 52, 562–565.
  PubMed CAS Google Scholar
• Montine T.J., Sidell K.R., Crews B.C., et al. (1999) Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology 53, 1495–1498.
  PubMed CAS Google Scholar
• Montine T.J., Markesbery W.R., Zackert W., et al. (1999) The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer’s disease patients. Am. J. Pathol. 155, 863–868.
  PubMed CAS Google Scholar
• Pratico D., Clark C.M., Lee V.M., et al. (2000) Increased 8,12-iso-iPF2alpha-VI in Alzheimer’s disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann. Neurol. 48, 809–812.
  Article PubMed CAS Google Scholar
• Tuppo E.E., Forman L.J., Spur B.W., et al. (2001) Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer’s disease. Brain Res. Bull. 54, 565–568.
  Article PubMed CAS Google Scholar
• Pratico D., Clark C.M., Liun F., et al. (2002) Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch. Neurol. 59, 972–976.
  Article PubMed Google Scholar
• Lovell M.A., Gabbita S.P., and Markesbery W.R. (1999) Increased DNA oxidation and decreased levels of repair products in Alzheimer’s disease ventricular CSF. J. Neurochem. 72, 771–776.
  Article PubMed CAS Google Scholar
• Tohgi H., Abe T., Yamazaki K., et al. (1998) The cerebrospinal fluid oxidized NO metabolites, nitrite and nitrate, in Alzheimer’s disease and vascular dementia of Binswanger type and multiple small infarct type. J. Neural Transm. 105, 1283–1291.
  Article PubMed CAS Google Scholar
• Tohgi H., Abe T., Yamazaki K., et al. (1999) Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer’s disease. Neurosci. Lett. 269, 52–54.
  Article PubMed CAS Google Scholar
• Perry G., Castellani R.J., Smith M.A., et al. (2003) Oxidative damage in the olfactory system in Alzheimer’s disease. Acta Neuropathol. (Berl.) 106, 552–556.
  Article CAS Google Scholar
• Mecocci P., Polidori M.C., Ingegni T., et al. (1998) Oxidative damage to DNA in lymphocytes from AD patients. Neurology 51, 1014–1017.
  PubMed CAS Google Scholar
• Mecocci P., Polidori M.C., Cherubini A., et al. (2002) Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch. Neurol. 59, 794–798.
  Article PubMed Google Scholar
• Gibson G.E., Pulsinelli W., Blass J.P., and Duffy T.E. (1981) Brain dysfunction in mild to moderate hypoxia. Am. J. Med. 70, 1247–1254.
  Article PubMed CAS Google Scholar
• Blass J.P. and Gibson G.E. (1999) Cerebrometabolic aspects of delirium in relationship to dementia. Dement. Geriatr. Cogn. Disord. 10, 335–338.
  Article PubMed CAS Google Scholar
• Small G.W., Mazziotta J.C., Collins M.T., et al. (1995) Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 273, 942–947.
  Article PubMed CAS Google Scholar
• Reiman E.M., Caselli R.J., Yun L.S., et al. (1996) Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 334, 752–758.
  Article PubMed CAS Google Scholar
• Ibanez V., Pietrini P., Alexander G.E., et al. (1998) Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer’s disease. Neurology 50, 1585–1593.
  PubMed CAS Google Scholar
• Gibson G.E., Sheu K.F., and Blass J.P. (1998) Abnormalities of mitochondrial enzymes in Alzheimer disease. J. Neural Transm. 105, 855–870.
  Article PubMed CAS Google Scholar
• Chandrasekaran K., Giordano T., Brady D.R., et al. (1994) Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res. Mol. Brain Res. 24, 336–340.
  Article PubMed CAS Google Scholar
• Cottrell D.A., Blakely E.L., Johnson M.A., et al. (2001) Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD. Neurology 57, 260–264.
  PubMed CAS Google Scholar
• Maurer I., Zierz S., and Moller H.J. (2000) A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol. Aging 21, 455–462.
  Article PubMed CAS Google Scholar
• Nagy Z., Esiri M.M., LeGris M., and Matthews P.M. (1999) Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology. Acta Neuropathol. (Berl.) 97, 346–354.
  Article CAS Google Scholar
• Parker W.D., Jr., Mahr N.J., Filley C.M., et al. (1994) Reduced platelet cytochrome c oxidase activity in Alzheimer’s disease. Neurology 44, 1086–1090.
  PubMed Google Scholar
• Parker W.D., Jr., Parks J., Filley C.M., and Kleinschmidt-DeMasters B.K. (1994) Electron transport chain defects in Alzheimer’s disease brain. Neurology 44, 1090–1096.
  PubMed Google Scholar
• Gibson G.E., Haroutunian V., Zhang H., et al. (2000) Mitochondrial damage in Alzheimer’s disease varies with apolipoprotein E genotype. Ann. Neurol. 48, 297–303.
  Article PubMed CAS Google Scholar
• Lovell M.A., Ehmann W.D., Butler S.M., and Markesbery W.R. (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer’s disease. Neurology 45, 1594–1601.
  PubMed CAS Google Scholar
• Kulkarni-Narla A., Getchell T.V., Schmitt F.A., and Getchell M.L. (1996) Manganese and copper-zinc superoxide dismutases in the human olfactory mucosa: increased immunoreactivity in Alzheimer’s disease. Exp. Neurol. 140, 115–125.
  Article PubMed CAS Google Scholar
• De Leo M.E., Borrello S., Passantino M., et al. (1998) Oxidative stress and overexpression of managanese superoxide dismutase in patients with Alzheimer’s disease. Neurosci. Lett. 250, 173–176.
  Article PubMed Google Scholar
• Ozcankaya R. and Delibas N. (2002) Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study. Croat. Med. J. 43, 28–32.
  PubMed Google Scholar
• Aksenov M.Y., Tucker H.M., Nair P., et al. (1998) The expression of key oxidative stress-handling genes in different brain regions in Alzheimer’s disease. J. Mol. Neurosci. 11, 151–164.
  Article PubMed CAS Google Scholar
• Serra J.A., Dominguez R.O., de Lustig E.S., et al. (2001) Parkinson’s disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson’s, Alzheimer’s and vascular dementia patients. J. Neural Transm. 108, 1135–1148.
  Article PubMed CAS Google Scholar
• Gulesserian T., Seidl R., Hardmeier R., et al. (2001) Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome. J. Invest. Med. 49, 41–46.
  CAS Google Scholar
• Behl C. (1997) Amyloid beta-protein toxicity and oxidative stress in Alzheimer’s disease. Cell Tissue Res. 290, 471–480.
  Article PubMed CAS Google Scholar
• Markesbery W.R. (1997) Oxidative stress hypothesis in Alzheimer’s disease. Free Radical Biol. Med. 23, 134–147.
  Article CAS Google Scholar
• Gsell W., Conrad R., Hickethier M., et al. (1995) Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J. Neurochem. 64, 1216–1223.
  Article PubMed CAS Google Scholar
• Takahashi M., Dore S., Ferris C.D., et al. (2000) Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer’s disease. Neuron 28, 461–473.
  Article PubMed CAS Google Scholar
• Behl C., Davis J.B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817–827.
  Article PubMed CAS Google Scholar
• Samudralwar D.L., Diprete C.C., Ni B.F., et al. (1995) Elemental imbalances in the olfactory pathway in Alzheimer’s disease. J. Neurol. Sci. 130, 139–145.
  Article PubMed CAS Google Scholar
• Smith M.A., Harris P.L., Sayre L.M., and Perry G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA 94, 9866–9868.
  Article PubMed CAS Google Scholar
• Deibel M.A., Ehmann W.D., and Markesbery W.R. (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress. J. Neurol. Sci. 143, 137–142.
  Article PubMed CAS Google Scholar
• Smith M.A., Wehr K., Harris P.L., et al. (1998) Abnormal localization of iron regulatory protein in Alzheimer’s disease. Brain Res. 788, 232–236.
  Article PubMed CAS Google Scholar
• Connor J.R., Snyder B.S., Arosio P., et al. (1995) A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer’s diseased brains. J. Neurochem. 65, 717–724.
  Article PubMed CAS Google Scholar
• Loeffler D.A., Connor J.R., Juneau P.L., et al. (1995) Transferrin and iron in normal, Alzheimer’s disease, and Parkinson’s disease brain regions. J. Neurochem. 65, 710–724.
  Article PubMed CAS Google Scholar
• Kato J. and Niitsu Y. (2002) Recent advance in molecular iron metabolism: translational disorders of ferritin. Int. J. Hematol. 76, 208–212.
  PubMed CAS Google Scholar
• Pinero D.J., Hu J. and Connor J.R. (2000) Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer’s diseased brains. Cell. Mol. Biol. (Noisy-le-grand). 46, 761–776.
  CAS Google Scholar
• Sayre L.M., Perry G., Harris P.L., et al. (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer’s disease: a central role for bound transition metals. J. Neurochem. 74, 270–279.
  Article PubMed CAS Google Scholar
• Ding Q. and Keller J.N. (2003) Does proteasome inhibition play a role in mediating neuropathology and neuron death in Alzheimer’s disease? J. Alzheimer’s Dis. 5, 241–245.
  CAS Google Scholar
• Raina A.K., Zhu X., Rottkamp C.A., et al. (2000) Cyclin’ toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J. Neurosci. Res. 61, 128–133.
  Article PubMed CAS Google Scholar
• Zhu X., Raina A.K., and Smith M.A. (1999) Cell cycle events in neurons. Proliferation or death? Am. J. Pathol. 155, 327–329.
  PubMed CAS Google Scholar
• Nagy Z., Esiri M.M., Cato A.M., and Smith A.D. (1997) Cell cycle markers in the hippocampus in Alzheimer’s disease. Acta Neuropathol. (Berl.) 94, 6–15.
  Article CAS Google Scholar
• Vincent I., Jicha G., Rosado M., and Dickson D.W. (1997) Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer’s disease brain. J. Neurosci. 17, 3588–3598.
  PubMed CAS Google Scholar
• Yang Y., Geldmacher D.S., and Herrup K. (2001) DNA replication precedes neuronal cell death in Alzheimer’s disease. J. Neurosci. 21, 2661–2668.
  PubMed CAS Google Scholar
• Zhu X., McShea A., Harris P.L., et al. (2004) Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer’s disease. J. Neurosci. Res. 75, 698–703.
  Article PubMed CAS Google Scholar
• Barni S., Sciola L., Spano A., and Pippia P. (1996) Static cytofluorometry and fluorescence morphology of mitochondria and DNA in proliferating fibroblasts. Biotech. Histochem. 71, 66–70.
  PubMed CAS Google Scholar
• Bowser R. and Smith M.A. (2002) Cell cycle proteins in Alzheimer’s disease: plenty of wheels but no cycle. J. Alzheimer’s Dis. 4, 249–254.
  CAS Google Scholar
• Smith M.A., Richey P.L., Taneda S., et al. (1994) Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer’s disease. Ann. NY Acad. Sci. 738, 447–454.
  Article PubMed CAS Google Scholar
• Smith M.A., Rudnicka-Nawrot M., Richey P.L., et al. (1995) Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer’s disease. J. Neurochem. 64, 2660–2666.
  Article PubMed CAS Google Scholar
• Smith M.A., Taneda S., Richey P.L., et al. (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA 91, 5710–5714.
  Article PubMed CAS Google Scholar
• Vitek M.P., Bhattacharya K., Glendening J.M., et al. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 4766–4770.
  Article PubMed CAS Google Scholar
• Castellani R.J., Harris P.L., Sayre L.M., et al. (2001) Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. Free Radical Biol. Med. 31, 175–180.
  Article CAS Google Scholar
• Nunomura A., Perry G., Aliev G., et al. (2001) Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759–767.
  PubMed CAS Google Scholar
• Nunomura A., Perry G., Pappolla M.A., et al. (2000) Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J. Neuropathol. Exp. Neurol. 59, 1011–1017.
  PubMed CAS Google Scholar
• Odetti P., Angelini G., Dapino D., et al. (1998) Early glycoxidation damage in brains from Down’s syndrome. Biochem. Biophys. Res. Commun. 243, 849–851.
  Article PubMed CAS Google Scholar
• Pratico D., Uryu K., Leight S., et al. (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21, 4183–4187.
  PubMed CAS Google Scholar
• Smith M.A., Hirai K., Hsiao K., et al. (1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70, 2212–2215.
  Article PubMed CAS Google Scholar
• Olivieri G., Baysang G., Meier F., et al. (2001) _N_-acetyl-l-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on beta-amyloid secretion and τ phosphorylation. J. Neurochem. 76, 224–233.
  Article PubMed CAS Google Scholar
• Misonou H., Morishima-Kawashima M., and Ihara Y. (2000) Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry 39, 6951–6959.
  Article PubMed CAS Google Scholar
• Frederikse P.H., Garland D., Zigler J.S., Jr., and Piatigorsky J. (1996) Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells. J. Biol. Chem. 271, 10,169–10,174.
  CAS Google Scholar
• Tamagno E., Bardini P., Obbili A., et al. (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol. Dis. 10, 279–288.
  Article PubMed CAS Google Scholar
• Dyrks T., Dyrks E., Hartmann T., et al. (1992) Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267, 18,210–18,217.
  CAS Google Scholar
• Atwood C.S., Moir R.D., Huang X., et al. (1998) Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273, 12,817–12,826.
  Article CAS Google Scholar
• Ono K., Hasegawa K., Naiki H., and Yamada M. (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitro. J. Neurosci. Res. 75, 742–750.
  Article PubMed CAS Google Scholar
• Frautschy S.A., Hu W., Kim P., et al. (2001) Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol. Aging 22, 993–1005.
  Article PubMed CAS Google Scholar
• Pappolla M., Bozner P., Soto C., et al. (1998) Inhibition of Alzheimer beta-fibrillogenesis by melatonin. J. Biol. Chem. 273, 7185–7188.
  Article PubMed CAS Google Scholar
• Hall E.D. and Braughler J.M. (1986) Role of lipid peroxidation in post-traumatic spinal cord degeneration: a review. Central Nerv. Syst. Trauma 3, 281–294.
  CAS Google Scholar
• Kitagawa K., Matsumoto M., Oda T., et al. (1990) Free radical generation during brief period of cerebral ischemia may trigger delayed neuronal death. Neuroscience 35, 551–558.
  Article PubMed CAS Google Scholar
• Jenner P., Dexter D.T., Sian J., et al. (1992) Oxidative stress as a cause of nigral cell death in Parkinson’s disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson’s Disease Research Group. Ann. Neurol. 32(Suppl.), S82-S87.
  Article PubMed CAS Google Scholar
• Geddes J.W., Tekirian T.L., Soultanian N.S., et al. (1997) Comparison of neuropathologic criteria for the diagnosis of Alzheimer’s disease. Neurobiol. Aging 18, S99-S105.
  Article PubMed CAS Google Scholar
• Gentleman S.M., Graham D.I., and Roberts G.W. (1993) Molecular pathology of head trauma: altered beta APP metabolism and the aetiology of Alzheimer’s disease. Prog. Brain. Res. 96, 237–246.
  PubMed CAS Google Scholar
• Roberts G.W., Gentleman S.M., Lynch A., et al. (1994) Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry. 57, 419–425.
  PubMed CAS Google Scholar
• Lim G.P., Chu T., Yang F., et al. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 8370–8377.
  PubMed CAS Google Scholar
• Sung S., Yao Y., Uryu K., et al. (2004) Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer’s disease. FASEB J. 18, 323–325.
  PubMed CAS Google Scholar
• Matsubara E., Bryant-Thomas T., Pacheco Quinto J., et al. (2003) Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer’s disease. J. Neurochem. 85, 1101–1108.
  Article PubMed CAS Google Scholar
• Veurink G., Liu D., Taddei K., et al. (2003) Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants. Free Radical Biol. Med. 34, 1070–1077.
  Article CAS Google Scholar
• Johnson G.V. and Bailey C.D. (2002) T, where are we now? J. Alzheimer’s Dis. 4, 375–398.
  CAS Google Scholar
• Gomez-Ramos A., Diaz-Nido J., Smith M.A., et al. (2003) Effect of the lipid peroxidation product acrolein on τ phosphorylation in neural cells. J. Neurosci. Res. 71, 863–870.
  Article PubMed CAS Google Scholar
• Ho P.I., Ortiz D., Rogers E., and Shea T.B. (2002) Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J. Neurosci. Res. 70, 694–702.
  Article PubMed CAS Google Scholar
• Olivieri G., Brack C., Muller-Spahn F., et al. (2000) Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and τ phosphorylation in SHSY5Y neuroblastoma cells. J. Neurochem. 74, 231–236.
  Article PubMed CAS Google Scholar
• Mattson M.P., Fu W., Waeg G., and Uchida K. (1997) 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein τ. Neuroreport. 8, 2275–2281.
  Article PubMed CAS Google Scholar
• Egana J.T., Zambrano C., Nunez M.T., et al. (2003) Iron-induced oxidative stress modify τ phosphorylation patterns in hippocampal cell cultures. Biometals 16, 215–223.
  Article PubMed CAS Google Scholar
• Ko L., Odawara T., and Yen S.H. (1997) Menadione-induced τ dephosphorylation in cultured human neuroblastoma cells. Brain Res. 760, 118–128.
  Article PubMed CAS Google Scholar
• Davis D.R., Anderton B.H., Brion J.P., et al. (1997) Oxidative stress induces dephosphorylation of τ in rat brain primary neuronal cultures. J. Neurochem. 68, 1590–1597.
  Article PubMed CAS Google Scholar
• Takeda A., Smith M.A., Avila J., et al. (2000) In Alzheimer’s disease, heme oxygenase is coincident with Alz50, an epitope of τ induced by 4-hydroxy-2-nonenal modification. J. Neurochem. 75, 1234–1241.
  Article PubMed CAS Google Scholar
• Perez M., Hernandez F., Gomez-Ramos A., et al. (2002) Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. Eur. J. Biochem. 269, 1484–1489.
  Article PubMed CAS Google Scholar
• Perez M., Cuadros R., Smith M.A., et al. (2000) Phosphorylated, but not native, τ protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal. FEBS Lett. 486, 270–274.
  Article PubMed CAS Google Scholar
• Wilson D.M. and Binder L.I. (1997) Free fatty acids stimulate the polymerization of τ and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer’s disease. Am. J. Pathol. 150, 2181–2195.
  PubMed CAS Google Scholar
• Gamblin T.C., King M.E., Dawson H., et al. (2000) In vitro polymerization of τ protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants. Biochemistry 39, 6136–6144.
  Article PubMed CAS Google Scholar
• Nacharaju P., Lewis J., Easson C., et al. (1999) Accelerated filament formation from τ protein with specific FTDP-17 missense mutations. FEBS Lett. 447, 195–199.
  Article PubMed CAS Google Scholar
• Gamblin T.C., King M.E., Kuret J., et al. (2000) Oxidative regulation of fatty acid-induced τ polymerization. Biochemistry 39, 14,203–14,210.
  CAS Google Scholar
• Smith M.A. (1998) Alzheimer disease. Int. Rev. Neurobiol. 42, 1–54.
  Article PubMed CAS Google Scholar
• Smith M.A., Casadesus G., Joseph J.A., and Perry G. (2002) Amyloid-beta and τ serve antioxidant functions in the aging and Alzheimer brain. Free Radical Biol. Med. 33, 1194–1999.
  Article CAS Google Scholar
• Lee H.G., Petersen R.B., Zhu X., et al. (2003) Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases? Brain Pathol. 13, 630–638.
  Article PubMed CAS Google Scholar
• Gomez-Isla T., Hollister R., West H., et al. (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer’s disease. Ann. Neurol. 41, 17–24.
  Article PubMed CAS Google Scholar
• Kril J.J., Patel S., Harding A.J., and Halliday G.M. (2002) Neuron loss from the hippocampus of Alzheimer’s disease exceeds extracellular neurofibrillary tangle formation. Acta Neuropathol. (Berl.) 103, 370–376.
  Article Google Scholar
• Morsch R., Simon W., and Coleman P.D. (1999) Neurons may live for decades with neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 58, 188–197.
  Article PubMed CAS Google Scholar
• Curtain C.C., Ali F., Volitakis I., et al. (2001) Alzheimer’s disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 276, 20,466–20,473.
  Article CAS Google Scholar
• Hock C., Golombowski S., Muller-Spahn F., et al. (1998) Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer’s disease and major depression—inverse correlation with dementia severity. Eur. Neurol. 39, 111–118.
  Article PubMed CAS Google Scholar
• Hou L., Kang I., Marchant R.E., and Zagorski M.G. (2002) Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1–42) peptide of Alzheimer’s disease. J. Biol. Chem. 277, 40,173–40,176.
  CAS Google Scholar
• Zou K., Gong J.S., Yanagisawa K., and Michikawa M. (2002) A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J. Neurosci. 22, 4833–4841.
  PubMed CAS Google Scholar
• Kontush A., Berndt C., Weber W., et al. (2001) Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. Free Radical Biol. Med. 30, 119–128.
  Article CAS Google Scholar